3,3-Diphenylpropylamine

3,3-Diphenylpropylamine
Names
Preferred IUPAC name
3,3-Diphenylpropan-1-amine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.024.532
UNII
  • InChI=1S/C15H17N/c16-12-11-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10,15H,11-12,16H2 checkY
    Key: KISZTEOELCMZPY-UHFFFAOYSA-N checkY
  • C1=CC=C(C=C1)C(CCN)C2=CC=CC=C2
Properties
C15H17N
Molar mass 211.308 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

3,3-Diphenylpropylamine is a form of diphenylpropylamine.

It is commonly conjugated to another agent giving a "bifunctional" molecule. Some such agents are used to treat cardiovascular diseases.

3,3-Diphenylpropylamine derivatives
Name Identifier Chemical structure
BIIA 0388 CID:9958467 [337359-07-6]
BZP derivative [1]
Droprenilamine [57653-27-7]
Delucemine [186495-49-8 ]
Fendiline [13042-18-7]
Lercanidipine [100427-26-7]
KD-983 [50597-65-4]
Mepramidil [23891-60-3]
Milverine [75437-14-8]
PF 244 Fb: [52017-07-9]
Prenylamine [390-64-7]
SoRI-20041 now SRI-20041
Tiopropamine [39516-21-7]
CB1 receptor ligand [117-34-0] [5586-73-2][2]


References

  1. ^ Tadayuki Suzuki & Toshiharu Megumi, U.S. patent 3,957,790 (1976 to Tokyo Tanabe Co Ltd).
  2. ^ Urbani, P., Cascio, M. G., Ramunno, A., Bisogno, T., Saturnino, C., Marzo, V. D. (August 2008). "Novel sterically hindered cannabinoid CB1 receptor ligands". Bioorganic & Medicinal Chemistry. 16 (15): 7510–7515. doi:10.1016/j.bmc.2008.06.001. hdl:11563/122572. PMID 18579386.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.